RUBIUS THERAPEUTICS, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [●], 202[●] Subordinated Debt SecuritiesIndenture • June 8th, 2022 • Rubius Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledJune 8th, 2022 Company Industry JurisdictionINDENTURE, dated as of [●], 202[●] , among RUBIUS THERAPEUTICS, INC.., a Delaware corporation (the “Company”), and [TRUSTEE] as trustee (the “Trustee”):